Neurocrine Biosciences | Revenu Net



Net Income Changement Date
AbbVie USD 938M 348M 2025-06
Acadia Pharmaceuticals USD 26.67M 7.68M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
ALKERMES USD 87.1M 64.63M 2025-06
Alnylam Pharmaceuticals USD -66277000 8.8M 2025-06
Amgen USD 1.43B 298M 2025-06
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Cytokinetics USD -134370000 27.01M 2025-06
Dynavax Technologies USD 18.72M 114.82M 2025-06
Exelixis USD 230.42M 70.8M 2025-07
Gilead Sciences USD 1.96B 645M 2025-06
Halozyme Therapeutics USD 165.16M 47.06M 2025-06
Incyte USD 405M 246.8M 2025-06
Ionis Pharmaceuticals USD 123.55M 270.49M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Pfizer USD 2.91B 58M 2025-06
Prothena USD -125770000 67.81M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Repligen USD 14.87M 9.04M 2025-06
Sarepta Therapeutics USD 196.89M 644.4M 2025-06
Teva Pharmaceutical Industries USD 282M 68M 2025-06
Ultragenyx Pharmaceutical USD -114951000 36.13M 2025-06
Vertex Pharmaceuticals USD 1.03B 386.6M 2025-06


Neurocrine Biosciences Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.